Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05492721 · ClinicalTrials.gov registry record · Phase 3
Comparing Tissue Adhesives in Port Site Closure
A Phase 3 study of Dermatitis, Contact, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 3
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT05492721 is a Phase 3 study of Dermatitis, Contact that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 180 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05492721, a Phase 3 study of Dermatitis, Contact, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a multi-center randomized controlled trial to evaluate two different methods of reinforcing surgical port site closure: 2-Octylcyanoacrylate and n-butyl-2-cyanoacrylate.
Conditions Studied
Interventions
- DEVICE 2-Octylcyanoacrylate
- DEVICE N-butyl-2-cyanoacrylate
Study Locations (1)
Texas
- Memorial Hermann - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2022-06-29 |
| Est. Completion | 2025-06-23 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05492721
The ClinicalTrials.gov registry entry for NCT05492721 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dermatitis, Contact appearing as the primary indexed condition, and to 2 interventions - of which 2-Octylcyanoacrylate is the first listed.
NCT05492721 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05492721 about?
NCT05492721 is a clinical study titled "Comparing Tissue Adhesives in Port Site Closure". This is a multi-center randomized controlled trial to evaluate two different methods of reinforcing surgical port site closure: 2-Octylcyanoacrylate and n-butyl-2-cyanoacrylate.
What is the current status of trial NCT05492721?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 180 participants. The study started on 2022-06-29. Estimated completion is 2025-06-23.
What conditions does trial NCT05492721 study?
This clinical trial studies the following conditions: Dermatitis, Contact.
What interventions are being tested in trial NCT05492721?
The interventions under investigation include: 2-Octylcyanoacrylate (DEVICE), N-butyl-2-cyanoacrylate (DEVICE).
Who is sponsoring clinical trial NCT05492721?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05492721 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.